Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;8(3):317-332.
doi: 10.1007/s13679-019-00352-2.

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives

Natalia Vallianou  1 , Theodora Stratigou  1 , Gerasimos Socrates Christodoulatos  2   3 , Maria Dalamaga  4
Affiliations
Review

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives

Natalia Vallianou et al. Curr Obes Rep. 2019 Sep.

Abstract

Purpose: In this review, we summarize current evidence on the gut microbiome and microbial metabolites in relation to obesity and obesity-associated metabolic disorders. Special emphasis is given on mechanisms interconnecting gut microbiome and microbial metabolites with metabolic disorders as well as on potential preventive and therapeutic perspectives with a "bench to bedside" approach.

Recent findings: Recent data have highlighted the role of gut dysbiosis in the etiology and pathogenesis of metabolic disorders, including obesity, metabolic syndrome, type 2 diabetes mellitus, and non-alcoholic fatty liver disease. Overall, most studies have demonstrated a reduction in gut microbiome diversity and richness in obese subjects, but there is still much debate on the exact microbial signature of a healthy or an obese gut microbiome. Despite the controversial role of an altered gut microbiome as a cause or consequence of obesity in human studies, numerous animal studies and certain human studies suggest beneficial metabolic effects of certain microbial intestinal metabolites, such as butyrate, that could be used in the prevention and treatment of obesity and its comorbidities. More randomized controlled trials and larger prospective studies including well-defined cohorts as well as a multi-omics approach are warranted to better identify the associations between the gut microbiome, microbial metabolites, and obesity and its metabolic complications.

Keywords: Diabetes; Gut; Intestine; Metabolic disorder; Metabolic syndrome; Metabolite; Microbiome; Microbiota; Non-alcoholic fatty liver disease; Obesity; Prebiotics; Probiotics; Synbiotics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Immunol. 1999 Jun 15;162(12):7454-60 - PubMed
    1. Am J Clin Nutr. 2000 May;71(5):1123-8 - PubMed
    1. Science. 2003 Feb 7;299(5608):853-5 - PubMed
    1. Ann Epidemiol. 2003 Nov;13(10):674-82 - PubMed
    1. Science. 2005 Mar 25;307(5717):1915-20 - PubMed

MeSH terms

LinkOut - more resources